CNO Financial Group (CNO) has drawn investor attention after its recent share price of US$55.21, with returns over the past month and past three months contrasting shorter term daily moves.
Recent trading has cooled slightly, with the 1-day share price return declining 0.65% and the 7-day share price return edging down 0.58%. Even so, CNO Financial Group still shows building momentum when you zoom out, supported by a 30.83% year-to-date share price return and a 40.87% total shareholder return over the past year.
Scan how CNO Financial Group’s recent momentum compares with peers by lining it up against a curated 35 high quality undervalued stocks that are combining stronger fundamentals with market skepticism.
CNO Financial Group has already rewarded holders over the past year, yet the recent cooling and a share price near US$55 raise a sharper question: Does the current valuation still leave enough upside for new buyers relative to the risks?
CNO Financial Group is trading at $55.21, slightly above the most followed fair value estimate of $53.50, which frames a modest valuation premium and puts the focus on whether the growth story and capital returns justify that gap.
Accelerating growth in annuity and life/health policy sales, particularly driven by a rapidly aging U.S. population (11,000 Americans turning 65 each day) and increased focus on retirement income solutions, is expanding CNO's addressable market and supporting consistent, repeatable revenue gains. Strong momentum in digital and web-based direct-to-consumer channels, evidenced by 39% year-over-year growth and over 30% of D2C leads now from digital sources, is reducing customer acquisition costs and is expected to drive further margin expansion and scalability.
See why 1 investors see CNO Financial Group as 3% overvalued.
The most widely followed narrative applies a 7.49% discount rate and arrives at a fair value of $53.50, which sits a little below where CNO Financial Group currently trades. That view leans on expectations for higher profit margins, a declining share count and a future P/E multiple just under 11x to support earnings growth and ongoing buybacks.
Result: Fair Value of $53.50 (OVERVALUED)
Still, CNO Financial Group’s story could be knocked off course if long term care claims trend less favorably or if digital focused rivals squeeze pricing power.
Find out about the key risks to this CNO Financial Group narrative.
Mixed signals on CNO Financial Group so far, with both risks and rewards in play, mean you are better off checking the underlying data yourself and pressure testing the thesis from your own angle. To weigh those trade offs in one place, start with the 1 key reward and 2 important warning signs.
Do not stop with CNO Financial Group alone. Use this momentum to look for additional opportunities that match your risk appetite and income goals.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com